Literature DB >> 15746962

The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.

Katherine L Dunn1, Paula S Espino, Bojan Drobic, Shihua He, James R Davie.   

Abstract

Stimulation of the Ras-mitogen-activated protein kinase (MAPK) signal transduction pathway results in a multitude of events including expression of the immediate-early genes, c-fos and c-myc. Downstream targets of this stimulated pathway are the mitogen- and stress-activated protein kinases (MSK) 1 and 2, which are histone H3 kinases. In chromatin immunoprecipitation assays, it has been shown that the mitogen-induced phosphorylated H3 is associated with the immediate-early genes and that MSK1/2 activity and H3 phosphorylation have roles in chromatin remodeling and transcription of these genes. In oncogene-transformed fibroblasts in which the Ras-MAPK pathway is constitutively active, histone H1 and H3 phosphorylation is increased and the chromatin of these cells has a more relaxed structure than the parental cells. In this review we explore the deregulation of the Ras-MAPK pathway in cancer, with an emphasis on breast cancer. We discuss the features of MSK1 and 2 and the impact of a constitutively activated Ras-MAPK pathway on chromatin remodeling and gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746962     DOI: 10.1139/o04-121

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  90 in total

1.  A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Authors:  Elisabeth Simboeck; Anna Sawicka; Gordin Zupkovitz; Silvia Senese; Stefan Winter; Franck Dequiedt; Egon Ogris; Luciano Di Croce; Susanna Chiocca; Christian Seiser
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

2.  Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts.

Authors:  Beatriz Pérez-Cadahía; Bojan Drobic; Paula S Espino; Shihua He; Soma Mandal; Shannon Healy; James R Davie
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

Review 3.  Regulation of chromatin structure by histone H3S10 phosphorylation.

Authors:  Kristen M Johansen; Jørgen Johansen
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

4.  Mitogen-activated protein kinase signaling controls basal and oncostatin M-mediated JUNB gene expression.

Authors:  Mellissa J Hicks; Qiuping Hu; Erin Macrae; James DeWille
Journal:  Mol Cell Biochem       Date:  2015-02-08       Impact factor: 3.396

5.  Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines.

Authors:  S Hoffmann; A Burchert; A Wunderlich; Y Wang; S Lingelbach; L C Hofbauer; M Rothmund; A Zielke
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

6.  Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.

Authors:  Sabrina Lisi; Margherita Sisto; Domenico Ribatti; Massimo D'Amore; Raffella De Lucro; Maria Antonia Frassanito; Loredana Lorusso; Angelo Vacca; Dario Domenico Lofrumento
Journal:  J Mol Med (Berl)       Date:  2014-02-21       Impact factor: 4.599

Review 7.  Polarity proteins as regulators of cell junction complexes: implications for breast cancer.

Authors:  Dana Bazzoun; Sophie Lelièvre; Rabih Talhouk
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

8.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.

Authors:  Alexander Köenig; Thomas Linhart; Katrin Schlengemann; Kristina Reutlinger; Jessica Wegele; Guido Adler; Garima Singh; Leonie Hofmann; Steffen Kunsch; Thomas Büch; Eva Schäfer; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

9.  Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.

Authors:  Hong-Gyum Kim; Ki Won Lee; Yong-Yeon Cho; Nam Joo Kang; Sang-Muk Oh; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

10.  A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells.

Authors:  Trish T Hoang; I Caglar Tanrikulu; Quinn A Vatland; Trieu M Hoang; Ronald T Raines
Journal:  Mol Cancer Ther       Date:  2018-10-03       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.